checkAd

    DGAP-News  593  0 Kommentare Alliance Growers Announces Letter of Intent with WFS Pharmagreen, Including Subsidiary Canna Companion

    DGAP-News: Alliance Growers Corp. / Key word(s): Miscellaneous
    Alliance Growers Announces Letter of Intent with WFS Pharmagreen, Including
    Subsidiary Canna Companion

    30.06.2016 / 17:04
    The issuer is solely responsible for the content of this announcement.

    ---------------------------------------------------------------------------


    Vancouver, British Columbia--(Newsfile Corp. - June 30, 2016) - Alliance
    Growers Corp. (CSE: ACG) ('Alliance Growers' or the 'Company') is pleased
    to announce it has signed a Letter of Intent with WFS Pharmagreen Inc.
    ('Pharmagreen') where it has previously been agreed that Pharmagreen will
    provide information about its business and its wholly owned subsidiary,
    Canna Companion Products Inc. ('Canna'). Alliance Growers proposes to work
    with and investigate possible joint business interests and opportunities
    with Pharmagreen and Canna, including a potential full merger of
    Pharmagreen and Alliance Growers, subject to extensive due diligence and
    analysis.

    Commenting on the acquisition, Dennis Petke, Alliance Growers President and
    CEO said, 'We are absolutely thrilled to have entered into an LOI with
    Pharmagreen. This presents an opportunity for Alliance Growers to rapidly
    build out our 'Four Pillars' Business Divisions ahead of schedule. This
    will definitely provide almost immediate value for Alliance Growers
    shareholders.'

    The initial step is a proposal to obtain an exclusive license from
    Pharmagreen for the marketing, distribution and sales of all present and
    future Tissue Culture plantlet products utilizing the proprietary
    'Chibafreen Invitro Plant Production System' for the jurisdiction of
    Canada, for a fee of CAD$400,000. Consistent quality for mass production
    for the agriculture and marijuana industry stems from disease-free,
    genetically identical, healthy starting plant material that can only be
    truly achieved through Chibafreen Invitro technology.

    The execution of the formal license agreement shall be on or before the
    closing of the Financing referred to below. Additionally both parties agree
    to possible further development of a 'Full Spectrum DNA Botany Lab', which
    would be the only such lab facility in Western Canada. A unique blend of
    clean room lab facilities including a botanical oils extraction lab would
    be built under the heading of 'Botany Center'. Licensing opportunities for
    the 'Botany Center' for the UK and European Union are subject to further
    negotiations and terms.

    Peter Wojcik, CEO of Pharmagreen, stated, 'We are very happy to be working
    with the Alliance Growers' team. They are a very professional group that
    Seite 1 von 4


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News Alliance Growers Announces Letter of Intent with WFS Pharmagreen, Including Subsidiary Canna Companion DGAP-News: Alliance Growers Corp. / Key word(s): Miscellaneous Alliance Growers Announces Letter of Intent with WFS Pharmagreen, Including Subsidiary Canna Companion 30.06.2016 / 17:04 The issuer is solely responsible for the content of this …